Processa Pharmaceuticals Stock Forecast

Sell candidate since Jun 03, 2026 Loss -22.86%

The Processa Pharmaceuticals Inc. stock price gained 9.64% on the last trading day (Friday, 10th Jul 2026), rising from $1.97 to $2.16. During the last trading day the stock fluctuated 15.08% from a day low at $1.95 to a day high of $2.24. The price has risen in 5 of the last 10 days and is up by 14.29% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 28 thousand more shares were traded than the day before. In total, 83 thousand shares were bought and sold for approximately $178.22 thousand.

The stockhas broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $2.01, a level that may pose a second chance to hit a runner. According to fan-theory $2.42 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

PCSA Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, June 26, 2026, and so far it has risen 16.13%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Processa Pharmaceuticals Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Processa Pharmaceuticals Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $2.25. On a fall, the stock will find some support from the short-term average at $2.02. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for Processa Pharmaceuticals Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $2.04 and $1.98. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Processa Pharmaceuticals Inc. finds support just below today's level at $2.04. If this is broken, then the next support from accumulated volume will be at $1.98 and $1.89.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.293 between high and low, or 15.08%. For the last week, the stock has had daily average volatility of 12.65%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PCSA) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect Processa Pharmaceuticals Inc. to open at $2.11, and during the day (based on 14 day Average True Range), to move between $2.04 and $2.28, which gives a possible trading interval of +/-$0.237 (+/-11.60%) up or down from last closing price. If Processa Pharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 11.60% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.04 (5.79%) than the resistance at $2.37 (9.72%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Processa Pharmaceuticals Inc. stock A Buy?

Processa Pharmaceuticals Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.010 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 13, 2026 - $2.11 ( 2.11%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk